These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 12808132)
1. Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Pinschewer DD; Perez M; Sanchez AB; de la Torre JC Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7895-900. PubMed ID: 12808132 [TBL] [Abstract][Full Text] [Related]
2. Development of live-attenuated arenavirus vaccines based on codon deoptimization. Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652 [TBL] [Abstract][Full Text] [Related]
3. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines. Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555 [TBL] [Abstract][Full Text] [Related]
4. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. Beyer WR; Pöpplau D; Garten W; von Laer D; Lenz O J Virol; 2003 Mar; 77(5):2866-72. PubMed ID: 12584310 [TBL] [Abstract][Full Text] [Related]
5. Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice. Iwasaki M; Ng CT; Cubitt B; de la Torre JC J Virol; 2016 Nov; 90(22):10102-10112. PubMed ID: 27581982 [TBL] [Abstract][Full Text] [Related]
6. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. Beyer WR; Westphal M; Ostertag W; von Laer D J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421 [TBL] [Abstract][Full Text] [Related]
8. Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. Lee KJ; Perez M; Pinschewer DD; de la Torre JC J Virol; 2002 Jun; 76(12):6393-7. PubMed ID: 12021374 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. Martínez-Sobrido L; Zúñiga EI; Rosario D; García-Sastre A; de la Torre JC J Virol; 2006 Sep; 80(18):9192-9. PubMed ID: 16940530 [TBL] [Abstract][Full Text] [Related]
10. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. Lee KJ; Novella IS; Teng MN; Oldstone MB; de La Torre JC J Virol; 2000 Apr; 74(8):3470-7. PubMed ID: 10729120 [TBL] [Abstract][Full Text] [Related]
11. Rescue of the prototypic Arenavirus LCMV entirely from plasmid. Sánchez AB; de la Torre JC Virology; 2006 Jul; 350(2):370-80. PubMed ID: 16476461 [TBL] [Abstract][Full Text] [Related]
12. Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes. Pinschewer DD; Flatz L; Steinborn R; Horvath E; Fernandez M; Lutz H; Suter M; Bergthaler A Int Immunol; 2010 Sep; 22(9):749-56. PubMed ID: 20584765 [TBL] [Abstract][Full Text] [Related]
13. Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. Pinschewer DD; Perez M; de la Torre JC J Virol; 2003 Mar; 77(6):3882-7. PubMed ID: 12610166 [TBL] [Abstract][Full Text] [Related]
14. RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. Cornu TI; de la Torre JC J Virol; 2001 Oct; 75(19):9415-26. PubMed ID: 11533204 [TBL] [Abstract][Full Text] [Related]
15. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501 [TBL] [Abstract][Full Text] [Related]
16. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Emonet SF; Garidou L; McGavern DB; de la Torre JC Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3473-8. PubMed ID: 19208813 [TBL] [Abstract][Full Text] [Related]
17. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. Rojek JM; Sanchez AB; Nguyen NT; de la Torre JC; Kunz S J Virol; 2008 Aug; 82(15):7677-87. PubMed ID: 18508885 [TBL] [Abstract][Full Text] [Related]
18. General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines. Iwasaki M; Ngo N; Cubitt B; Teijaro JR; de la Torre JC J Virol; 2015 Dec; 89(23):12166-77. PubMed ID: 26401045 [TBL] [Abstract][Full Text] [Related]
19. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. Salvato M; Borrow P; Shimomaye E; Oldstone MB J Virol; 1991 Apr; 65(4):1863-9. PubMed ID: 1840619 [TBL] [Abstract][Full Text] [Related]
20. Molecular Engineering of a Mammarenavirus with Unbreachable Attenuation. Sakabe S; Cubitt B; Martinez-Sobrido L; de la Torre JC J Virol; 2023 Jan; 97(1):e0138522. PubMed ID: 36533953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]